Français
ItalianoBond AbbVie 4.95% ( US00287YDT38 ) in USD
| Issuer | AbbVie | ||||||||||||||||||||
| Market price |  100.12 % ▼ |
||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||
| ISIN code |
 US00287YDT38 ( in USD )
|
||||||||||||||||||||
| Interest rate | 4.95% per year ( payment 2 times a year) | ||||||||||||||||||||
| Maturity | 15/03/2031 | ||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||
| Total amount | 2 000 000 000 USD | ||||||||||||||||||||
| Cusip | 00287YDT3 | ||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||
| Next Coupon | 15/09/2026 ( In 20 days ) | ||||||||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YDT38, pays a coupon of 4.95% per year. The coupons are paid 2 times per year and the Bond maturity is 15/03/2031 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YDT38, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YDT38, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||
| |||||||||||||||||||||